TRANSITION SERVICES AGREEMENT by and among ADMA BIO CENTERS GEORGIA INC. and ADMA BIOLOGICS, INC. and BIOTEST PHARMACEUTICALS CORPORATION Effective as of January 1, 2019Transition Services Agreement • March 13th, 2019 • Adma Biologics, Inc. • Biological products, (no disgnostic substances) • Delaware
This TRANSITION SERVICES AGREEMENT (this “Agreement”), with an effective date of January 1, 2019 (the “Effective Date”), is entered into by and among ADMA Biologics, Inc., a Delaware corporation (“ADMA Biologics”), ADMA Bio Centers Georgia Inc., a Delaware corporation (“ADMA Bio Centers”) (collectively “ADMA”), and Biotest Pharmaceuticals Corporation, a Delaware corporation (“BPC”). ADMA and BPC shall be separately referred to herein as a “Party” and together as the “Parties.”
